Catheter-based treatments for hepatic metastases from neuroendocrine tumors.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25247935.
- Also identified by DOI 10.2214/AJR.14.12983.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this article is to present our experience in treating patients with hepatic metastases from a neuroendocrine primary malignancy. The tumor and patient characteristics, vascular access, and features of treatment all play a role in the long-term management of patients with metatastic neuroendocrine tumors. Routine prophylactic measures are recommended to reduce the frequency and severity of crisis events related to hormone release in patients with neuroendocrine tumors.
Medical subject headings
- Catheter Ablation
- Liver Neoplasms
- Neuroendocrine Tumors
- Radiography, Interventional